drugset / Trial / NCT00453336

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

NCT00453336

Phase 2 Completed 45 enrolled University of Miami
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, precancerous cells and cancer cells are killed. PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy with porfimer sodium works in treating patients with precancerous lesions, cancer, or other disease of the aerodigestive tract.

Timeline

Start
2003-06
Primary completion
2009-08
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule 2 mg/kg Intravenous